Multiple Organ Dysfunction Syndrome clinical trials at UCSF

1 research study open to eligible people

Multiple organ dysfunction syndrome means two or more organs stop working during a severe illness. UCSF is studying anakinra, a drug that reduces inflammation in children with sepsis-related MODS. UCSF is also gathering blood samples and health data from patients with organ failure.

Showing trials for

  • Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS

    open to eligible people ages up to 17 years

    The TRIPS study is a prospective, multi-center, double-blind, adaptively randomized, placebo-controlled clinical trial of the drug anakinra for reversal of moderate to severe hyperinflammation in children with sepsis-induced multiple organ dysfunction syndrome (MODS).

    Oakland, California and other locations

Last updated: